Is there enough patient demand, payer opportunity, and referral capacity in this market?
A Physician’s Guide to Medical Practice Market Feasibility
A medical practice is feasible when patient need can become reachable, collectible, and sustainable demand for the specific model you intend to operate. Population growth, a shortage designation, long wait times, or physician anecdotes can support the case—but none proves payer access, referral conversion, patient choice, capacity, or financial viability by itself.
Executive summary · approximately two minutes
Need is not demand, and demand is not revenue.
Market feasibility asks whether a particular practice—offering defined services to defined patients through defined access, payer, referral, and operating pathways—has a credible reason to exist in a particular market. It is narrower and more useful than saying that healthcare demand is growing or that a community needs more clinicians.
The U.S. Small Business Administration recommends examining demand, market size, economic indicators, location, saturation, pricing, competition, barriers, and alternatives. In healthcare, the inquiry also needs age and condition patterns, insurance coverage, payer products, referral flows, scheduling access, provider supply, facility dependencies, patient travel, service substitution, clinical scope, and the revenue-cycle implications of the intended model.
Federal sources can strengthen the evidence. Census Business Builder provides demographic and economic data. HRSA publishes shortage-area and workforce information. CMS provides public doctor and clinician data. These sources describe parts of the market. They must be reconciled with local payer information, directories, referral interviews, wait-time checks, primary research, and the practice’s own capacity and financial model.
The direct answer
A feasible market needs three connected proofs.
Define geography, patient segment, condition or service need, demographics, growth, travel patterns, and access barriers relevant to the intended scope.
A broad population count is not a patient forecast.Test existing supply, wait times, hours, payer participation, referral behavior, patient preferences, alternatives, and the practice’s credible differentiation.
A shortage label can coexist with operational barriers.Connect reachable patients to capacity, visits or procedures, payer mix, allowed amounts, collections, variable cost, staffing, space, and runway.
Market evidence must reconcile with the pro forma.Why should I care?
A community can have unmet need and still be a difficult place to build your model.
Healthcare need may not convert into practice volume when patients lack coverage, the intended payer products are closed, referrals are controlled by competing systems, travel patterns favor another location, existing practices have unused capacity, the service requires unavailable facilities, or the practice cannot recruit the team needed to deliver care.
The reverse can also occur. A market may appear well supplied in provider counts while patients face long waits, narrow networks, limited language access, inconvenient hours, weak continuity, or a mismatch between available services and the population’s needs. Counts become useful only when connected to access and behavior.
HRSA’s 2025 primary-care workforce report documents substantial national shortages and geographic maldistribution, including counties without a primary-care physician. Those findings are important context for primary care, but national and shortage-area data cannot establish the viability of a specific specialty, site, payer strategy, or business model.
Business terms to know
Use market words precisely enough to test them.
- Service area
- The geography from which the practice can realistically draw patients, defined by specialty, access, travel, referral, payer, and competitive behavior—not only mileage.
- Population need
- The prevalence, incidence, demographics, access gaps, or health conditions suggesting that services may be beneficial.
- Reachable demand
- The portion of need that can realistically select and access the practice through its location, hours, referral, technology, price, payer, and capacity.
- Provider supply
- Clinicians or organizations offering substitutable services in the relevant geography, payer products, settings, and access channels.
- Market saturation
- The degree to which available alternatives already meet or exceed reachable demand for the defined service and patient segment.
- Payer opportunity
- A credible pathway to participate in or serve relevant insurance products or payment segments under workable economic and operational terms.
- Referral capacity
- The realistic ability of referral sources, partners, and patient self-referral channels to identify, direct, and complete appropriate patient access.
- Triangulation
- Using multiple independent data types to test the same conclusion and investigate meaningful disagreement among them.
What is it?
Build the feasibility case from evidence that can disagree.
A strong analysis does not force every source to tell the same story. It records what each source measures, what it misses, and how conflicting signals change the decision.
Define the exact model and decision
State the physician type, services, patient segments, payer or payment model, setting, hours, capacity, geography, and the commitment being considered.
Map population and health need
Use dated population, age, income, insurance, growth, disease, utilization, language, mobility, and access data that actually relate to the service.
Measure supply and substitutes
Identify physicians, APPs, hospitals, health systems, retail, virtual, urgent, direct-pay, and other alternatives by product, specialty, location, access, and capacity.
Test access friction
Check appointment availability, wait times, hours, patient travel, network participation, referral rules, facility requirements, technology, language, and affordability.
Test payer and referral pathways
Verify target products, network openness, enrollment timing, contract economics, referral sources, leakage, affiliation patterns, and the evidence supporting conversion.
Run primary research
Use structured interviews, directory validation, mystery-shopper access checks where lawful, community conversations, and referral-source feedback to test gaps in secondary data.
Translate evidence into the operating model
Connect demand cases to provider capacity, staffing, schedule, no-shows, service mix, payer mix, allowed amounts, collection timing, variable cost, space, and capital.
Write disconfirming triggers
Identify evidence that would reduce the forecast, change location or scope, require more capital, support a staged launch, or stop the project.
Show me
Use an evidence ledger—not a market-story collage.
Each material conclusion should show the source, date, geographic and service fit, limitation, planning implication, and next validation step.
| Question | Evidence source | What it can support | What it cannot prove |
|---|---|---|---|
| Who lives here? | Census/ACS, population estimates, local planning data | Population size, age, income, growth, household and geographic context | Service utilization, payer access, or patient choice |
| Is there documented shortage? | HRSA HPSA/MUA data and workforce projections | Designated shortage context and workforce maldistribution | Viability of this specialty, site, payer mix, or practice |
| Who already provides care? | CMS data, payer directories, NPPES, state records, health-system sites | Named clinicians, organizations, locations, and public affiliations | Current capacity, complete network status, wait time, or service quality |
| Can patients get appointments? | Structured calls, online scheduling checks, referral interviews, patient research | Observed access friction, hours, scheduling, and stated barriers | Total market size or long-term demand |
| Can referrals reach us? | Referral-source interviews, discharge patterns, affiliations, network rules | Potential pathways, needs, friction, and relationship requirements | Guaranteed referral volume |
| Can claims become cash? | Payer product analysis, contracts, fee schedules, eligibility, collection data | Products, economics, billing conditions, and collection assumptions | Enrollment approval, perfect collections, or future payer behavior |
| Can we serve the demand? | Capacity model, staffing plan, space, technology, facility and clinical dependencies | Operational volume ceiling and resource requirements | Patient acquisition or profitability without the rest of the model |
Put me in the chair
The county is growing and designated as a shortage area.
The physician assumes that the designation guarantees volume. The target commercial network may be closed, the preferred site is difficult to reach, a health system controls major referrals, and the forecast uses a national visit rate without local validation.
The practice treats population growth and shortage status as a complete forecast and commits to the full site and staffing model.
Hidden riskNeed without access
Demographics, supply, wait times, payer products, referrals, patient access, competition, and primary research are reconciled.
Management gainEvidence by pathway
The model launches only at the capacity, space, and capital level supported by conservative demand and explicit validation gates.
Decision standardProof before scale
Defend the decision
Can you distinguish population need from reachable demand?
Choose an answer. The page will explain the reasoning immediately; the goal is market judgment, not a guaranteed forecast.
HRSA identifies the location as a primary-care shortage area. What does that prove for a new specialty practice?
A payer directory lists only two local competitors. What is the strongest interpretation?
Interviews suggest long waits, but the conservative pro forma still requires more visits than the planned team can deliver. What should happen?
Strong work. You are testing whether need can move through access, payment, referral, and operating pathways—not merely counting people or competitors.
Open the complete 12-question review checklist
- Is the exact physician, service, patient, payment, setting, capacity, and geographic model defined?
- Is the service area based on real patient travel, referral, payer, access, and competitive behavior rather than an arbitrary radius?
- Are population, age, income, insurance, growth, language, mobility, and health-need data current, relevant, and dated?
- Have provider supply and substitutable alternatives been identified by specialty, product, location, service, setting, and access channel?
- Have directories and public listings been checked for accuracy, duplication, inactive records, scope, and product limitations?
- Are appointment availability, wait times, hours, travel, language, digital access, and affordability tested with primary evidence?
- Are target payer products, network openness, contract economics, enrollment timing, and collection implications separately verified?
- Are referral sources, affiliations, leakage, discharge patterns, direct access, and relationship requirements mapped without assuming guaranteed volume?
- Have at least two independent evidence types been used for each material demand conclusion?
- Do conservative demand cases reconcile with provider capacity, staffing, schedule, no-shows, space, technology, and facility dependencies?
- Do payer mix, service mix, allowed amount, collection, variable cost, and ramp assumptions reconcile with the feasibility evidence and pro forma?
- Are disconfirming evidence, sensitivity cases, validation steps, decision gates, owner, and next action documented?
Common mistakes and hidden risks
A polished market story can still be built from incompatible evidence.
Counting the wrong geography
A convenient radius replaces the real service area shaped by travel, referral, network, specialty, and patient behavior.
Shortage equals success
A designation is treated as proof of payer access, volume, staff availability, or collectible revenue.
Directory literalism
Duplicate, inactive, incomplete, or product-specific listings are treated as a complete competitive map.
Need without affordability
Health need is counted without testing coverage, price, transportation, language, referral, or scheduling barriers.
Referral promises
Friendly conversations or letters of support become guaranteed volume in the forecast.
National averages as local facts
Utilization, payer mix, compensation, or visit assumptions are imported without local reconciliation.
Demand beyond capacity
The forecast exceeds the visits, procedures, staff, rooms, schedule, or facility access the practice can deliver.
No disconfirming test
Research is collected only to support the preferred answer, leaving no evidence threshold that could change it.
The MedCBO perspective
“A market is not feasible because it needs care. It is feasible when the practice can reach the right patients, deliver the right services, and convert that access into sustainable operations.”
Physicians should see the evidence chain—not only a consultant’s conclusion. A defensible feasibility analysis identifies what is known, what is estimated, where the sources disagree, how the evidence changes the operating and financial model, and which assumption must be validated before the next commitment.
When market evidence becomes practice-specific
Talk through your practice plans.
If your location, service line, payer strategy, or referral model depends on assumptions that are difficult to reconcile, a MedCBO discovery conversation can help identify which evidence and operating dependencies need closer validation. The discussion is exploratory and focused on alignment—not a sales pitch.
Apply the lesson
Connect market evidence to payer mix, capital, and opening scale.
Payer-Mix Sensitivity Tool
Test how changes in payer mix and reimbursement assumptions affect collections, contribution, and break-even volume.
Frequently asked questions
Questions physicians ask about practice-market feasibility.
How large should the service area be?
Does a Health Professional Shortage Area designation prove my practice will succeed?
How do I count competitors accurately?
Can I use national utilization or payer-mix benchmarks?
Are letters of support from referral sources enough?
When is the market analysis complete?
Sources and further reading
Evidence used in this guide.
SBA and Census sources support market-research structure and demographic/economic evidence. HRSA sources support primary-care shortage and workforce context. CMS supports public doctor and clinician data. AMA supports physician-practice startup considerations. None provides a guaranteed local patient-volume forecast.
- U.S. Small Business Administration (current page accessed July 30, 2026). Plan your business. View SBA planning guidance.
- U.S. Census Bureau (2026, March 19). Census Business Builder. Open Census Business Builder.
- Health Resources and Services Administration (current dashboard accessed July 30, 2026). Health Workforce Shortage Areas. Explore HRSA shortage-area data.
- Health Resources and Services Administration (2025, December). State of the Primary Care Workforce, 2025. Read the HRSA workforce report.
- Centers for Medicare & Medicaid Services (2026). Care Compare: Doctors and Clinicians Initiative. View CMS provider-data resources.
- American Medical Association (2025, June 4). Getting started in private practice. View AMA startup guidance.
This guide is for general educational and planning purposes. It does not establish patient demand, community need, a shortage, network adequacy, payer participation, referral volume, market share, service-area boundaries, utilization, reimbursement, collection, financing, profitability, or business viability for any physician, entity, service, location, payer, product, or population, and it does not create a client relationship. Public data may be delayed, incomplete, estimated, differently defined, or inaccurate for the intended use. Laws, payer networks, directories, population conditions, provider supply, affiliations, contracts, access, and competition change. Verify material assumptions with current primary data, payers, regulators, qualified healthcare counsel, financial advisors, local stakeholders, and other appropriate experts before committing capital, signing a lease, hiring, representing network status, or opening.